[1]
“Transcriptomic and Proteomic Profiling of Circulating Tumor Cells to Identify Predictive Biomarkers of Chemotherapeutic Response in Triple-Negative Breast Cancer”, ICMERD-IJMS, vol. 3, no. 1, pp. 1–7, Jan. 2022, Accessed: Jul. 14, 2025. [Online]. Available: https://icmerd.com/index.php/ICMERD-IJMS/article/view/ICMERD-IJMS_03_01_001